title: Novel Therapeutic Targets of Pulmonary Hypertension.
authors.affiliation: From the Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
authors.forename: Nobuhiro
authors.initials: N
authors.lastname: Yaoita
authors.affiliation: From the Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
authors.forename: Kimio
authors.initials: K
authors.lastname: Satoh
authors.affiliation: From the Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan. shimo@cardio.med.tohoku.ac.jp.
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Shimokawa
mesh_terms: D055372:AMP-Activated Protein Kinases / Q000187:drug effects; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D051926:Basigin / Q000187:drug effects; D025901:Carboxypeptidase B2 / Q000502:physiology; D021983:Cyclophilins / Q000187:drug effects; D004730:Endothelium, Vascular / Q000187:drug effects; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000503:physiopathology; D009131:Muscle, Smooth, Vascular / Q000166:cytology; D032389:Myocytes, Smooth Muscle / Q000187:drug effects; D054460:rho-Associated Kinases / Q000187:drug effects
chemical_list: D000959:Antihypertensive Agents; D051926:Basigin; D054460:rho-Associated Kinases; D055372:AMP-Activated Protein Kinases; D025901:Carboxypeptidase B2; D021983:Cyclophilins
keywords: AMP-activated kinase; cyclophilin; heart failure; pulmonary hypertension; rho-associated kinase; thrombin-activatable fibrinolysis inhibitor